Welcome


Welcome to BioSentinel Pharmaceuticals!

• BioSentinel Pharmaceuticals
      BioSentinel's mission is the development of innovative tools and reagents for the study of botulinum neurotoxin (BoNT). Using technology licensed from the Wisconsin Alumni Research Foundation (WARF) and based on the work from the University of Wisconsin, our lab in the University Research Park has been creating technology advancements for improved BoNT research and detection since mid-2007.

      We believe our tests and assays are setting a new standard for speed, accuracy, and low cost. BoTest™ A/E BoNT Detection Kit, our first product, is an in vitro assay (For non-clinical research purposes only) that can be used in low or high throughput formats using standard fluorescent plate readers. We look forward to taking your orders, answering your questions, and furthering your research.


• Future Releases
      Please watch this space on our website for information about the future release of BoTest™ Matrix E and F, BoCell™ A, a cell-based assay for botulinum; and other products in the pipeline.

 News:
BioSentinel Launches Third Product, BoTest™ Matrix A, for Detection of Botulinum A in Complex Matrices (June 15, 2011)
http://www.biosentinelpharma.com/news.php


MADISON, WI – BioSentinel, Inc., a start-up biodefense company founded in 2007 and based on University of Wisconsin-Madison technology licensed from the Wisconsin Alumni Research Foundation (WARF), has released its third product, BoTest™ Matrix A Botulinum Neurotoxin Kit (BoTest™ Matrix A)... [read more]
Madison technology firm BioSentinel will present at botulism research meeting (October 14, 2010)
www.biosentinelpharma.com/news.php
Madison technology firm BioSentinel will present at botulism research meeting

MADISON, Wis. – Madison startup company BioSentinel, Inc. has been recognized for its industry leading research and will have six presentations at the 47th Annual Interagency Botulism Research Coordinating Commi... [read more]
BioSentinel among 2010 “Wisconsin Companies to Watch” (March 15, 2010)
http://www.biosentinelpharma.com/news.php
MADISON – BioSentinel LLC has been recognized as one of nearly 30 “Wisconsin Companies to Watch,” a new awards program for second-stage companies.

The awards are presented by the Wisconsin Entrepreneurs’ Network with support from the Wisconsin Department of Commerce and the Division of E... [read more]